$1.91
N/A
Last update: Nov 5, 4:00 PM
Foghorn Therapeutics Inc
FHTXNASDAQ
The average analyst price target for Foghorn Therapeutics is $10.33, 442.3% above the current price. Of 10 analysts, 7 rate it Buy and 3 Hold. Targets range from $2 to $20. The latest change came on Oct 2, 2026, when Wedbush downgraded Foghorn Therapeutics from Outperform to Neutral and moved its price target from $10 to $2.
Price Target Range — 10 Quarters
Analyst Consensus — 10 Analysts
Rating Trend — Last 9 Months
